Study to Assess the Effects of Esketamine on Safety of On-road Driving in Healthy Participants
Clinical trial NCT02228239 · COMPLETED
Trial details
- NCT number
- NCT02228239
- Sponsor
- Janssen Research & Development, LLC
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2014-09-01
- Primary completion
- 2014-12-01
- Enrollment
- 26
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.